Aphria Inc. (TSX: APH) (OTC: APHQF) announced this morning that the company has signed an exclusive cannabis supply agreement with a non-disclosed Argentina based pharmaceutical import and distribution company.
The non-disclosed company is currently licensed to import, sell and distribute medical products and derivatives to the people of Argentina. Under the terms of the agreement, Aphria will beome the exclusive supplier of cannabis products to the company.
At the importer’s request, financial terms and the name of the importer of the agreement are not being released.
“We are excited to enter the Argentinian market through this initial supply agreement,” said Vic Neufeld, CEO of Aphria. “We see tremendous potential for medical cannabis in several emerging markets in South America, including Argentina. As the leading low-cost supplier of high-quality medical cannabis, Aphria will continue to expand its global leadership through strategic investments, partnerships
and exclusive agreements such as this one.”